TP53 and non-small cell lung carcinoma: The CCK-8 cytotoxicity assay demonstrated that FOSB overexpression markedly increased the cisplatin sensitivity in NSCLC cells expressing p53-WT, while particularly reduced the cisplatin sensitivity in those expressing mutant p53-R248Q (Fig. 3I).